Skip to search formSkip to main contentSkip to account menu

Cyanidanol-3

Known as: Cyanidanol 3 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1989
1989
Male NMRI mice were treated i.p. with dichlorovinylcysteine (DCVC) in a dosage of 2.5‐500 mg/kg−1 and renal cortical slices from… 
1989
1989
The authors investigated the effects of (+) cyanidanol-3-(Catergen) in vitro on the activities of rat brain plasma membrane and… 
1989
1989
Liver cirrhosis is a very common illnesses and currently its treatment remains unpromising. In a research line devoted to… 
1987
1987
Antibiotic pretreatment significantly altered metabolism of (+)-catechin (cyanidanol-3) in the rat, with decreases in both the… 
Review
1984
Review
1984
In the therapy of chronic liver diseases several drugs are currently used. This review summarizes the results of the authors in… 
1984
1984
The authors examined the effect in vivo and in vitro of Catergen (cyanidanol-3) on demonstrable lysosomal enzyme activity in the… 
1983
1983
(+)Cyanidanol-3, a substance belonging to the flavonoids group, has been used in acute viral hepatitis (AVH) and chronic active… 
1982
1982
The major urinary metabolites of (+)-catechin (cyanidanol-3) in the rat were (+)-catechin glucuronide, 3′-O-methyl-(+)-catechin… 
1980
1980
SummaryPretreatment of rats with (+)cyanidanol-3 decreases the alterations in liver function tests (transaminase and bilirubin…